|
CLS Cell Lines Service GmbH
human prostate cancer cell lines Human Prostate Cancer Cell Lines, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/LNCaP+Cells/10__1158_slash_0008___5472__can___20___1965-51-0-6 Average 94 stars, based on 1 article reviews
human prostate cancer cell lines - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
lncap cells lysates ![]() Lncap Cells Lysates, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/LNCaP+Cell+Lysate/pmc01950328-99-0-8 Average 93 stars, based on 1 article reviews
lncap cells lysates - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Johns Hopkins HealthCare
lncap prostatic adenocarcinoma cells ![]() Lncap Prostatic Adenocarcinoma Cells, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/lncap+prostatic+adenocarcinoma+cells/10__1128_slash_mcb__14__3__1815-48-0-11 Average 90 stars, based on 1 article reviews
lncap prostatic adenocarcinoma cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Genentech inc
lncap prostate cancer cells expressing low (lncap-wt) and high levels (lncap-mt) of matriptase ![]() Lncap Prostate Cancer Cells Expressing Low (Lncap Wt) And High Levels (Lncap Mt) Of Matriptase, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/lncap+prostate+cancer+cells+expressing+low++lncap+wt++and+high+levels++lncap+mt++of+matriptase/pm20672321-62-12-22 Average 90 stars, based on 1 article reviews
lncap prostate cancer cells expressing low (lncap-wt) and high levels (lncap-mt) of matriptase - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
China Center for Type Culture Collection
lncap cell line ![]() Lncap Cell Line, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/cell+line+lncap/pmc08797366-37-1-8 Average 90 stars, based on 1 article reviews
lncap cell line - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Promega
ar-hibit ki lncap cells ![]() Ar Hibit Ki Lncap Cells, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/ar+hibit+ki+lncap+cells/pmc10982999__jm3c02123_si_001-140-0-7 Average 90 stars, based on 1 article reviews
ar-hibit ki lncap cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
HFK Bioscience
lncap cells ![]() Lncap Cells, supplied by HFK Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/lncap+cells/pmc03902919-96-19-6 Average 90 stars, based on 1 article reviews
lncap cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
luciferase expressing lncap cells ![]() Luciferase Expressing Lncap Cells, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/luciferase+expressing+lncap+cells/us08512701-804-0-11 Average 90 stars, based on 1 article reviews
luciferase expressing lncap cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
MAVER Laboratories
cell line lncap clone maver-1 ![]() Cell Line Lncap Clone Maver 1, supplied by MAVER Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/cell+line+lncap+clone+maver+1/us12172989-2432-8-8 Average 90 stars, based on 1 article reviews
cell line lncap clone maver-1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
HansaBioMed ltd
commercially available exosomes from the psa-expressing cell line lncap ![]() Commercially Available Exosomes From The Psa Expressing Cell Line Lncap, supplied by HansaBioMed ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/commercially+available+exosomes+from+the+psa+expressing+cell+line+lncap/pm36948237-79-8-12 Average 90 stars, based on 1 article reviews
commercially available exosomes from the psa-expressing cell line lncap - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
lncap cells ![]() Lncap Cells, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/lncap+cells/pm35337061-146-21-25 Average 90 stars, based on 1 article reviews
lncap cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
UroCor Inc
human prostate cancer cell lines lncap ![]() Human Prostate Cancer Cell Lines Lncap, supplied by UroCor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/lncap+cells/human+prostate+cancer+cell+line+lncap/10__1158_slash_0008___5472__can___06___1488-47-0-6 Average 90 stars, based on 1 article reviews
human prostate cancer cell lines lncap - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: EMBO Reports
Article Title: New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
doi: 10.1038/sj.embor.7401046
Figure Lengend Snippet: Androgen receptor-bound gene promoters identified by ChIP-chip. ( A ) AR ChIP-chip profiles of eight AR target gene promoters from vehicle (+EtOH)- and androgen (+R1881)-treated experiments. Genomic locations are indicated on the x axis and enrichment compared with total input DNA is shown on the y axis. ( B ) AR ChIP and qPCR analysis of 26 AR promoter targets in LNCaP cells. ( C ) AR ChIP and qPCR analysis of eight promoter targets in DUCaP cells. Relative enrichment by ChIP was quantified by using the standard curve method following 1 h with vehicle (EtOH) or androgen (R1881) relative to β-actin control and total genomic DNA input (see the online for details). Values are the averages of replicate experiments. Enrichment scores (S) and Wilcoxon scores (W) from LNCaP AR ChIP-chip analysis are indicated next to corresponding genes. AR, androgen receptor; ChIP, chromatin immunoprecipitation; ChIP-chip, ChIP with on-array detection; Chr, chromosome; EtOH, ethyl alcohol; KLK, human glandular kellikrein; qPCR, quantitative PCR.
Article Snippet:
Techniques: ChIP-chip, Control, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction
Journal: EMBO Reports
Article Title: New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
doi: 10.1038/sj.embor.7401046
Figure Lengend Snippet: ETS1 and androgen receptor interaction. ( A ) Sequence logos for ETS1 and AR ChIP-chip-enriched motifs 9 and 1. ( B ) UCSC Genome Browser tracks showing 15-bp ARE, 6-bp AR ‘half-site' and ETS1 motif occurrence in UNQ9419, CCNG2 and PRAME promoters. Locations of AR ChIP-chip peaks are indicated; darker boxes represent higher signal. ( C ) ETS1 ChIP and qPCR for UNQ9419, CCNG2 and PRAME promoters from vehicle (+EtOH)- and androgen (R1881)-treated experiments. ( D , E ) Quantitative real-time PCR of ETS1, UNQ9419, CCNG2 and PRAME 48 h after transfection with an ETS1 RNAi construct (pSR-ETS1) or a scrambled control (pS-Scr) ( D ) and ETS1 expression construct (+ETS1) or an empty vector control (pSG5) ( E ). qPCR data were quantified using the standard curve method, values relative to control sample and averages of replicate experiments. ( F , G ) Confocal microscopy images of LNCaP cells treated with androgen (+R1881) or vehicle (+EtOH) for 1 h. Cells were transfected with either AR–GFP expression construct ( F ) or pSG5 empty vector ( G ) and stained for AR (N20) and ETS1 (C20 and 1G11), as indicated. AR, androgen receptor; ARE, androgen-receptor elements; ChIP, chromatin immunoprecipitation; ChIP-chip, ChIP with on-assay detection; DAPI, 4′, 6′-diamidino-2-phenylindole; ETS, avian erythroblastosis virus E26 homologue; GFP, green fluorescent protein; qPCR, quantitative PCR; RNAi, RNA interference.
Article Snippet:
Techniques: Sequencing, ChIP-chip, Real-time Polymerase Chain Reaction, Transfection, Construct, Control, Expressing, Plasmid Preparation, Confocal Microscopy, Staining, Chromatin Immunoprecipitation, Virus
Journal: Nucleic Acids Research
Article Title: REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
doi: 10.1093/nar/gkt921
Figure Lengend Snippet: Analysis of ARORs by ChIP. ( A ) Quantitative PCR analysis of AR binding to promoter region of ARE– and RE-1–containing genes in LNCaP cells treated or not with DHT for 2 h. All gene names are provided by genenames.org. Students t -test was used to analyze the statistical significance of the differences observed on DHT treated versus control samples (* P < 0.05 and ** P < 0.01). ( B ) Heat map illustrating changes in expression on androgen or bicalutamide treatment for genes whose promoters bind AR in ChIP analysis. Data were obtained from GEO database ( http://www.ncbi.nlm.nih.gov/geo/ ). The experiments accession numbers are indicated ( C ) ChIP microarray analysis. The number of regions containing binding sites for the indicated transcription factors within AROR (dark gray) or a set of control regions that did not bind the AR in the ChIP microarray analysis, denoted as controls (light gray). Only the TFBS, with a statistically significant ( P < 0.05, χ2 analysis) overrepresentation within AROR, are shown. The transcription factor binding sites are named using JASPAR similarity matrix names as follows: REST, repressor element-1 silencing transcription factor; PPARG, peroxisome proliferation activated receptor gamma; AR, androgen receptor; NFκB, nuclear factor of kappa light polypeptide gene enhancer in B cells; D-Vit, vitamin D receptor; ESR1, estrogen receptor 1; MIZF, histone H4 transcription factor; bZIP911, ELK4, ETS domain proteins; E2F1, E2F transcription factor; Su(H), suppressor of hairless; NR2F1, nuclear receptor subfamily 2, group F, member 1; MAX MYC, Myc associated factor X; RREB1, Ras-responsive element binding protein 1; T, T box protein; TEAD1, transcriptional enhancer factor TEF1; and NR2F1, nuclear receptor subfamily 2, group F, family 1. ( D ) ChIP analysis of REST binding to promoter region of ARE and RE-1 containing genes in LNCaP cells treated or not with DHT for 2 h. The statistical significance was analyzed using Students t -test (* P < 0.01).
Article Snippet: Eight male athymic Balb/c nude mice (
Techniques: Real-time Polymerase Chain Reaction, Binding Assay, Expressing, Microarray
Journal: Nucleic Acids Research
Article Title: REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
doi: 10.1093/nar/gkt921
Figure Lengend Snippet: In situ proximity ligation assays. ( A ) Representative images of REST/AR co-localization in situ visualized by the proximity ligation assays. LNCaP cells were stained with REST and/or AR antibodies as indicated and subjected to proximity ligation assays to measure their co-localization in situ , visualized by the appearance of high-intensity fluorescent spots at the 634 nm wavelength. Two different antibodies recognizing the AR and raised from different species were used as positive controls. Analyses performed in the absence of one of the primary antibodies were used as negative controls. ( B ) The co-localization of AR and REST was analyzed by the quantification of the number of fluorescent spots localized in the nucleus of individual cells (α, P < 0.0001).
Article Snippet: Eight male athymic Balb/c nude mice (
Techniques: In Situ, Ligation, Staining
Journal: Nucleic Acids Research
Article Title: REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
doi: 10.1093/nar/gkt921
Figure Lengend Snippet: Androgens regulate REST function. ( A ) LNCaP cells were starved from steroids and then treated with DHT for 24 h. RT-PCR was used to measure expression levels of four known REST target genes: BDNF, Grin2a, NTRK3 and Synapsin1. All differences were statistically significant (* P < 0.01). ( B ) In a pulse chase experiment, LNCaP cells were labeled with 35 S-methionine and treated for 2 and 4 h with androgen when REST was immunoprecipitated and analyzed by autoradiography. ( C ) LNCaP cells were transfected with two siRNA targeting either REST or the AR, followed by measurements of the mRNA levels of the indicated genes. Asterisks indicate statistically significant differences between the cells transfected with control siRNA and those targeting AR or REST (* P < 0.05, ** P < 0.01). Western blot shows protein levels of REST and AR after REST and AR knockdown. ( D ) A luciferase reporter construct driven by the synapsin 1 gene promoter region containing the REST response element (RE-1) and a variant in which the N-terminal half region of the RE element was deleted was used to assess REST-mediated repression in the cells transfected with siRNAs targeting the REST and AR in the presence and absence of androgens. Significant differences in the comparison between luciferase activity in the cells transfected with siControl and Syn-Luc and the other experimental groups are denoted by * P < 0.05 or ** P < 0.01. Significant differences between the control group–transfected Syn-luciferase mutant and the rest of the groups are marked with α, P < 0.01. ( E ) Measurement of REST and AR binding to chromatin regions within the promoters of BDNF, Syn1 and Grin2a genes containing an RE-1 or to the ARE in a PSA gene enhancer. The influence of DHT treatment on REST and AR chromatin binding was also measured. DNA quantization was performed by q-PCR. Means differences between IgG control ChIP and those performed with the indicated antibodies (AR or REST) were compared by Student’s t -test (* P < 0.01 and ** P < 0.05). The statistical differences between DHT treated and untreated samples was also analyzed (α denotes a P < 0.05) ( F ) Measurement of REST, AR and β-TRCP levels in LNCaP cells with the indicated treatments.
Article Snippet: Eight male athymic Balb/c nude mice (
Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Pulse Chase, Labeling, Immunoprecipitation, Autoradiography, Transfection, Western Blot, Luciferase, Construct, Variant Assay, Activity Assay, Mutagenesis, Binding Assay
Journal: Nucleic Acids Research
Article Title: REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
doi: 10.1093/nar/gkt921
Figure Lengend Snippet: REST regulates NE differentiation in LNCaP cells. ( A ) Protein levels of NE marker chromogranin A and REST in cells depleted of androgens for the indicated times in the presence and absence of DHT. ( B ) mRNA levels of the REST target genes: Grin2a and NTRK3 and NE marker chromogranin A in same experiment as above. ( C ) NE differentiation was quantified by analyzing the length of cytoplasmic extensions processes during androgen deprivation for 7 days or in cells grown in the presence of androgen (+DHT) but transfected with siRNAs targeting REST or the AR. Statistical analysis was performed using the Wilcox ranked test; asterisk denotes statistically significant differences ( P < 0.001) with the siControl +DHT group, while α denotes significant differences ( P < 0.001) in comparison with control nontransfected cells −DHT. ( D ) mRNA levels of CgA in REST and AR knockdowns (* P < 0.05, Student’s t -test). ( E ) Protein and mRNA levels of chromogranin A after 72- and 96-h treatment with AR antagonist MDV3100. ( F ) Chromogranin A and REST levels in LNCaP orhotopic xenograft grown in castrated or intact mice.
Article Snippet: Eight male athymic Balb/c nude mice (
Techniques: Marker, Transfection